NEW YORK (GenomeWeb News) - The US Department of Defense has awarded CombiMatrix a one-year, $2.2 million contract to continue developing its microarrays to detect pathogens and toxins for use in bio-terror defense, CombiMatrix said today.
 
The company said under earlier DoD-funded programs it “demonstrated that its products can “simultaneously detect toxins, viruses, and bacteria using its semiconductor-based microarrays.”
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study in JAMA finds that genetic tests might not be able to determine what diet is right for someone seeking to lose weight.

A genome-wide association study that linked common genetic variants to salivary gland carcinoma risk has been retracted, according to Retraction Watch.

Vampire bats' ability to live off blood is etched in their genomes and gut microbiomes, the Scientist reports.

In Genome Biology this week: peopling of the Sahara, epigenetic reprogramming analysis of liverwort, and more.